
http://eyepointpharma.com
EyePoint Pharmaceuticals, Inc. Company Intro
Specialty pharmaceutical company focused on preventing blindness through the development of innovative sustained-release drug products and technologies.
Industry
Healthcare
EyePoint Pharmaceuticals, Inc. Headquaters
480 Pleasant Street
Watertown,02472
United States
EyePoint Pharmaceuticals, Inc. Share price
17 May 2023 13:10 GMT
$5.98
-0.02 (-0.33 %)
EyePoint Pharmaceuticals, Inc. Market cap
$203.753 M
WMC RANKING
2023
EyePoint Pharmaceuticals, Inc. # 114
BiotechnologyLatest EyePoint Pharmaceuticals, Inc. News
02 Oct 2023
Eyepoint Pharmaceuticals EYPT Stock Forecast 2023, 2024 and 2025
Eyepoint Pharmaceuticals EYPT Stock Forecast 2023, 2024 and 2025: Checkout the latest prediction and news for Eyepoint Stock.
02 Oct 2023
Does Eyepoint Pharmaceuticals Inc (EYPT) Have What it Takes to be in Your Portfolio Monday?
A rating of 89 puts Eyepoint Pharmaceuticals Inc (EYPT) near the top of the Biotechnology industry according to.
02 Oct 2023
Does Eyepoint Pharmaceuticals Inc (EYPT) Have What it ...
Eyepoint Pharmaceuticals Inc also received an overall rating of 65, putting it above 65% of all stocks. Biotechnology is ranked 83 out of the 148 industries.
WMC Market Score
WMC Market to Revenue Score
EyePoint Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
EyePoint Pharmaceuticals, Inc. | USD | $34,271 | $64,818 | $-44,500 | $2,038M | 114 |
Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total EyePoint Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
EyePoint Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
EyePoint Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
EyePoint Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
EyePoint Pharmaceuticals, Inc. WMC Market Score Calculations
Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
EyePoint Pharmaceuticals, Inc. | 0.37 | 5.10 | 0.04 | 0 | 0 | 0 | 2.22 |
Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge